Additionally, a combination of proteomic and transcriptomic readouts, for example, quantitative profiling of extracellular RNA and targeted analysis of specific markers, including PCA3, a non‐coding RNA known for its high specificity in PCa diagnosis, is proposed in further investigations. This evidence concerns the gene PCA3 and posterior cortical atrophy.